Saturday, August 11, 2018

India’s Hetero pulls heart drug from U.S. amid cancer risk probes

A unit of India’s Hetero Drugs is recalling some batches of the blood pressure and heart medicine valsartan in the United States, a notice on the U.S. regulator's website said, amid a wider probe into cancer risks associated with the drug.
https://ift.tt/2vANHRh support@endlesssupplies.biz (Endless Supplies .Biz) August 11, 2018 at 04:00AM

No comments: